Effect of SGLT2 inhibitors on body composition, fluid status and renin–angiotensin–aldosterone system in type 2 diabetes: a prospective study using bioimpedance spectroscopy

Overview of attention for article published in Cardiovascular Diabetology, April 2019

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#38 of 1,688)
High Attention Score compared to outputs of the same age (94th percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

blogs: 1 blog

twitter: 81 X users

Citations

dimensions_citation: 160 Dimensions

Readers on

mendeley: 157 Mendeley

Summary Blogs X Dimensions citations

So far, Altmetric has seen 90 X posts from 81 X users, with an upper bound of 222,232 followers.

@AKoutnik @CSaenzPhD It does seem SGLT2 inhibition increases RAAS levels in the blood in the short term but they return to normal after a few months. https://t.co/Arl5PSoql6

24 Nov 2021

Reply Repost Favourite

More on this here: https://t.co/ZD3AjCHZvE

21 Jan 2021

Reply Repost Favourite

@eric_weinhandl @mikejohansenmd @NEJM But in spite of my love for number 2, actual data suggest an increase in peripheral renin activity and a tendency toward higher aldo that do not persist for > 6 months under SGLT2i therapy https://t.co/m2LYzNmyKX

24 Oct 2020

Reply Repost Favourite

@ChristosArgyrop @kidney_boy @edgarvlermamd @hswapnil @scoca @GeorgeVasquezR2 @aishaikh True, but are not SGLT2i supposed to slightly increase RRAS? For instance, https://t.co/KlTJmj0uKd https://t.co/2rUXxlsx9c

07 Oct 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 86 additional X posts.